Cefoxitin sodium

头孢西丁钠

Report date: 2023/10/25 20:10:10
NME

Base Information

Drug NameCefoxitin sodium
Drug Alias Name头孢西丁钠美福仙cefoxitinumcefoxitina头孢西丁钠盐Mefoxin +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsEndometritis +[11] 
Global Approved IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsEndometritis +[8] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1995/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMylan Nv
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MichiganB Braun MedicalHaikou Pharmaceutical Factory Co Ltd
Inactive CompaniesMerck & Co Inc
Active IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsEndometritis +[9] 
Inactive IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections

Other Information

ATC CodeJ01DC01
Related LinksWikipediaDrugBankKEGG